Search

Chan, E. M., T. Shibue, J. M. McFarland, B. Gaeta, M. Ghandi, N. Dumont, A. Gonzalez, et al. 2019. “WRN Helicase Is a Synthetic Lethal Target in Microsatellite Unstable Cancers”. Nature 568: 551-56.

Chen, L., G. Alexe, N. V. Dharia, L. Ross, A. B. Iniguez, A. S. Conway, E. J. Wang, et al. 2018. “CRISPR-Cas9 Screen Reveals a MYCN-Amplified Neuroblastoma Dependency on EZH2”. J Clin Invest 128: 446-62.

Chiu, H. S., M. R. Martinez, M. Bansal, A. Subramanian, T. R. Golub, X. Yang, P. Sumazin, and A. Califano. 2017. “High-Throughput Validation of CeRNA Regulatory Networks”. BMC Genomics 18: 418.

Clifton, M. C., D. M. Dranow, A. Leed, B. Fulroth, J. W. Fairman, J. Abendroth, K. A. Atkins, et al. 2015. “A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1”. PLoS One 10: e0125010.

Corsello, S. M., R. T. Nagari, R. D. Spangler, J. Rossen, M. Kocak, J. G. Bryan, R. Humeidi, et al. 2020. “Discovering the Anti-Cancer Potential of Non-Oncology Drugs by Systematic Viability Profiling”. Nat Cancer 1: 235-48.

Cowley, G. S., B. A. Weir, F. Vazquez, P. Tamayo, J. A. Scott, S. Rusin, A. East-Seletsky, et al. 2014. “Parallel Genome-Scale Loss of Function Screens in 216 Cancer Cell Lines for the Identification of Context-Specific Genetic Dependencies”. Sci Data 1: 140035.

Dempster, J. M., C. Pacini, S. Pantel, F. M. Behan, T. Green, J. Krill-Burger, C. M. Beaver, et al. 2019. “Agreement Between Two Large Pan-Cancer CRISPR-Cas9 Gene Dependency Data Sets”. Nat Commun 10: 5817.

Adalsteinsson, V. A., G. Ha, S. S. Freeman, A. D. Choudhury, D. G. Stover, H. A. Parsons, G. Gydush, et al. 2017. “Scalable Whole-Exome Sequencing of Cell-Free DNA Reveals High Concordance With Metastatic Tumors”. Nat Commun 8: 1324.

Antipova, A. A., P. Tamayo, and T. R. Golub. 2002. “A Strategy for Oligonucleotide Microarray Probe Reduction”. Genome Biol 3: RESEARCH0073.

Armstrong, S. A., A. L. Kung, M. E. Mabon, L. B. Silverman, R. W. Stam, M. L. Den Boer, R. Pieters, et al. 2003. “Inhibition of FLT3 in MLL. Validation of a Therapeutic Target Identified by Gene Expression Based Classification”. Cancer Cell 3: 173-83.